UBS Group AG - JASPER THERAPEUTICS INC ownership

JASPER THERAPEUTICS INC's ticker is and the CUSIP is 471871103. A total of 24 filers reported holding JASPER THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of JASPER THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$103,450
-30.1%
215,521
+14.6%
0.00%
Q3 2022$148,000
+1245.5%
188,026
+3294.6%
0.00%
Q2 2022$11,000
-45.0%
5,539
+117.0%
0.00%
Q4 2021$20,000
+233.3%
2,552
+373.5%
0.00%
Q3 2021$6,0005390.00%
Other shareholders
JASPER THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Qiming U.S. Ventures Management, LLC 8,519,648$5,963,7547.92%
Velan Capital Investment Management LP 11,219,036$7,586,7976.12%
Ally Bridge Group (NY) LLC 3,144,164$2,200,9152.58%
Altium Capital Management LP 2,868,000$2,007,6001.05%
SPHERA FUNDS MANAGEMENT LTD. 5,687,134$3,980,9940.72%
Soleus Capital Management, L.P. 8,300,980$5,810,6860.54%
Octagon Capital Advisors LP 4,468,114$3,127,6800.48%
Saturn V Capital Management LP 1,387,015$970,9100.41%
Carlyle Group Inc. 8,761,891$6,054,4670.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 3,040,000$2,128,0000.24%
View complete list of JASPER THERAPEUTICS INC shareholders